Germany Gets Creative with Payer-Pharmaco Contracts
This article was originally published in The Pink Sheet Daily
Executive Summary
Rebate contracts between German insurance funds and generic firms have become widespread since, but the funds are increasingly negotiating deals on innovator drugs as well.